📰
Politics
Centerview’s Tokat Sees Potential for Mega Pharma Deals in 2026
📅11 March 2026 at 20:34
📰Bloomberg
👁️1 views
Share:
📰
Article Preview
Conditions could be ripe for the first $20 billion-plus biopharma deal in more than three years, according to Centerview Partners Co-President Eric Tokat. Tokat and Paul Weiss's Krishna Veeraraghavan joined Dani Burger and Michelle F. Davis on “Bloomberg Deals” for a roundtable to discuss their outlooks for biopharma M&A.
Original filename: 20260311_194745_Healthcare_M_A_Surges_Amid_Patent_Expirations_Experts_Discu.mp4 (Source: Bloomberg)
🎧
Listen to Preview
Audio version available
🔇
Audio Reader
Not supported in this browser
Want the full story?
Click below to load the complete article with full details, analysis, and context.
Share this story
Share:
Source: This article was originally published by Bloomberg. All rights reserved to the original publisher.
Comments
Loading comments...
Related Stories
Stay Updated
Get the latest Nigerian news delivered to your inbox.